KLF4 and triple-negative breast carcinoma: Small molecule inhibitors WX2-43 and MM-102 also inhibited KLF4 methylation and destabilized KLF4 by acting on methyltransferases to inhibit the progression of triple-negative breast cancer [168, 169].